A CLINICAL CASE OF LOWER RESPIRATORY TRACT INFECTION CAUSED BY ELIZABETHKINGIA MENINGOSEPTICA IN A CHILD WITH CEREBRAL PALSY
Abstract
The most common cause of morbidity and mortality in patients with cerebral palsy (Cerebral Palsy, CP), including in childhood, is associated with respiratory diseases. Patients with SR are characterized by a decrease in local immunity of the upper and lower respiratory tract, increased viral incidence, progression of a bacterial infection without additional infection or an increase in the number of microbial numbers, a decrease in lung function, and infection of the respiratory tract with a microfl ora atypical for practically healthy children. SR is a disease that occurs with severe comorbid conditions, it is epilepsy, requiring constant basic therapy, accompanied by standard negative side eff ects, it is both severe gastrointestinal problems and associated severe
nutritional status disorders, and defi cient conditions that contribute to infectious process against the background of SR. A clinical observation of a patient with SR who had severe community-acquired pneumonia caused by Elizabethkingia meningoseptica, which developed while taking glucocorticosteroids, is described. The diffi culties of managing a child when prescribing empirical antimicrobial therapy and successful eradication of the pathogen with clinical and radiological recovery of the patient after the detection of Elizabethkingia meningoseptica in the bronchoalveolar lavage fl uid and the appointment of antibiotic therapy based on the results of the obtained antibiogram are described. The authors draw attention to the pathogenetic features of the implementation of respiratory and nutritional disorders in a cohort of patients with SR and the need to personalize diagnostic and therapeutic measures in each case.
References
Rakocevic G., Alexopoulos H., Dalakas M.C. Quantitative clinical and autoimmune assessments in stiff person syndrome: evidence for a progressive disorder. BMC Neurol. 2019; 19(1): 1.
Ryan J.M., Peterson M.D., Ryan N. et al. Mortality due to cardiovascular disease, respiratory disease, and cancer in adults with cerebral palsy. Dev Med Child Neurol. 2019; 61(8): 924–8.
Himmelmann K., Sundh V. Survival with cerebral palsy over five decades in western Sweden. Dev Med Child Neurol. 2015; 57(8): 762–7.
Myers L.L., Nerminathan A., Fitzgerald D.A. et al. Transition to adult care for young people with cerebral palsy. Paediatr Respir Rev. 2020; 33: 16–23.
Gerdung C.A., Tsang A., Yasseen A.S. 3rd. et al. Association Between Chronic Aspiration and Chronic Airway Infection with Pseudomonas aeruginosa and Other Gram-Negative Bacteria in Children with Cerebral Palsy. Lung. 2016; 194(2): 307–14. DOI: 10.1007/s00408-016-9856-5. Epub 2016 Feb 16. PMID: 26883134.
Marpole R., Blackmore A.M., Gibson N. et al. Evaluation and Management of Respiratory Illness in Children With Cerebral Palsy. Front Pediatr. 2020; 8: 333. DOI: 10.3389/fped.2020.00333. PMID: 32671000; PMCID: PMC7326778.
Blackmore A.M., Bear N., Blair E. et al. Prevalence of symptoms associated with respiratory illness in children and young people with cerebral palsy. Dev Med Child Neurol. 2016; 58(7): 780–1.
Blackmore A.M., Bear N., Blair E. et al. Factors Associated with Respiratory Illness in Children and Young Adults with Cerebral Palsy. J Pediatr. 2016; 168: 151–7.e1.
Bonadies L., Zaramella P., Porzionato A. et al. Present and Future of Bronchopulmonary Dysplasia. J Clin Med. 2020; 9(5): 1539. DOI: 10.3390/jcm9051539. PMID: 32443685; PMCID: PMC7290764.
Govindaswamy A., Bajpai V., Trikha V. et al. Multidrug resistant Elizabethkingia meningoseptica bacteremia — Experience from a level 1 trauma centre in India. Intractable Rare Dis Res. 2018; 7(3): 172–6. DOI: 10.5582/irdr.2018.01077. PMID: 30181936; PMCID: PMC6119665.
Lau S.K., Chow W.-N., Foo C.-H. et al. Elizabethkingia anophelis bacteremia is associated with clinically significant infections and high mortality. Sci. Rep. 2016; 6: 26045. DOI: 10.1038/srep26045.
Dziuban E.J., Franks J.L., So M. et al. Elizabethkingia in children: A comprehensive review of symptomatic cases reported from 1944 to 2017. Clin. Infect. Dis. 2018; 67: 144–9. DOI: 10.1093/cid/cix1052.
Opota O., Diene S.M., Bertelli C. et al. Genome of the carbapenemase-producing clinical isolate Elizabethkingia miricola EM_CHUV and comparative genomics with Elizabethkingia meningoseptica and Elizabethkingia anophelis: Evidence for intrinsic multidrug resistance trait of emerging pathogens. Int. J. Antimicrob. Agents. 2017; 49: 93–7. DOI: 10.1016/j.ijantimicag.2016.09.031.
Swain B., Rout S., Otta S., Rakshit A. Elizabethkingia meningoseptica: An unusual cause for septicaemia. JMM Case Rep. 2015; 2: e000005. DOI: 10.1099/jmmcr.0.000005.
Lee C.-H., Lin W.-C., Chia J.-H. et al. Community-acquired osteomyelitis caused by Chryseobacterium meningosepticum: Case report and literature review. Diagn. Microbiol. Infect. Dis. 2008; 60: 89–93. DOI: 10.1016/j.diagmicrobio.2007.07.009.
Gupta P., Zaman K., Mohan B., Taneja N. Elizabethkingia miricola: A rare non-fermenter causing urinary tract infection. World J. Clin. Cases. 2017; 5: 187. DOI: 10.12998/wjcc.v5.i5.187.
Raghavan S., Thomas B., Shastry B. Elizabethkingia meningoseptica: Emerging multidrug resistance in a nosocomial pathogen. Case Rep. 2017; 2017: bcr-2017-221076. DOI: 10.1136/bcr-2017-221076.
Young S.M., Lingam G., Tambyah P.A. Elizabethkingia meningoseptica Engodenous Endophthalmitis — A Case Report. Antimicrob. Resist. Infect. Control. 2014; 3: 35. DOI: 10.1186/2047-2994-3-35.
Yang J., Xue W., Yu X. Elizabethkingia meningosepticum endocarditis: A rare case and special therapy. Anatol. J. Cardiol. 2015; 15: 427. DOI: 10.5152/akd.2015.6014.
Chi S., Fekete T. Epididymo-orchitis. In: Schlossberg D., editor. Clinical Infectious Disease. 2nd ed. Cambridge University Press; Cambridge, UK. 2015: 401–5.
Gonzalez C., Coolen-Allou N., Allyn J. et al. Severe sepsis and pulmonary abscess with bacteremia due to Elizabethkingia miricola. Med. Mal. Infect. 2015; 46: 49–51. DOI: 10.1016/j.medmal.2015.10.011.
aufiq Kadafi K., Yuliarto S., Aji Cahyono H. et al. Cerebral Salt Wasting Due to Bacteremia Caused by Elizabethkingia meningoseptica: A Case Report. Arch. Pediatr. Infect. Dis. 2020; 8: e44832. DOI: 10.5812/pedinfect.88432.
Kenna D.T., Fuller A., Martin K. et al. rpoB gene sequencing highlights the prevalence of an E. miricola cluster over other Elizabethkingia species among UK cystic fibrosis patients. Diagn. Microbiol. Infect. Dis. 2018; 90: 109–14. DOI: 10.1016/j.diagmicrobio.2017.10.014.
Amir A., IC Sam J., Nawi S. Elizabethkingia meningoseptica neonatal meningitis in a premature infant. Asian J. Med. Biomed. 2018; 2(Suppl. 1): 22.
Seong H., Kim J.H., Kim J.H. et al. Risk factors for mortality in patients with elizabethkingia infection and the clinical impact of the antimicrobial susceptibility patterns of elizabethkingia species. J. Clin. Med. 2020; 9: 1431. DOI: 10.3390/jcm9051431.
Nori P., Cowman K., Chen V. et al. Bacterial and fungal coinfections in COVID-19 patients hospitalized during the New York City pandemic surge. Infect. Control Hosp. Epidemiol. 2021; 42: 84–8. DOI: 10.1017/ice.2020.368.
Yang C., Liu Z., Yu S. et al. Comparison of three species of Elizabethkingia genus by whole-genome sequence analysis. FEMS Microbiol. Lett. 2021; 368: fnab018. DOI: 10.1093/femsle/fnab018.
King E.O. Studies on a group of previously unclassified bacteria associated with meningitis in infants. Am. J. Clin. Pathol. 1959; 31: 241–7. DOI: 10.1093/ajcp/31.3.241.
Nicholson A.C., Gulvik C.A., Whitney A.M. et al. Revisiting the taxonomy of the genus Elizabethkingia using whole-genome sequencing, optical mapping, and MALDI-TOF, along with proposal of three novel Elizabethkingia species: Elizabethkingia bruuniana sp. nov., Elizabethkingia ursingii sp. nov., and Elizabethkingia occulta sp. nov. Antonie Van Leeuwenhoek. 2018; 111: 55–72. DOI: 10.1007/s10482-017-0926-3.
Hwang J.-H., Kim J., Kim J.-H., Mo S. Elizabethkingia argenteiflava sp. nov., isolated from the pod of soybean, Glycine max. Int. J. Syst. Evol. Microbiol. 2021; 71: 004767. DOI: 10.1099/ijsem.0.004767.
Hem S., Jarocki V.M., Baker D.J. et al. Genomic analysis of Elizabethkingia species from aquatic environments: Evidence for potential clinical transmission. Curr. Res. Microb. Sci. 2022; 3: 100083. DOI: 10.1016/j.crmicr.2021.100083.
Zajmi A., Teo J., Yeo C.C. Epidemiology and Characteristics of Elizabethkingia spp. Infections in Southeast Asia. Microorganisms. 2022; 10(5): 882. DOI: 10.3390/microorganisms10050882. PMID: 35630327; PMCID: PMC9144721.
Breurec S., Criscuolo A., Diancourt L. et al. Genomic epidemiology and global diversity of the emerging bacterial pathogen Elizabethkingia anophelis. Sci. Rep. 2016; 6: 30379. DOI: 10.1038/srep30379.
Lin J.-N., Lai C.-H., Yang C.-H., Huang Y.-H. Elizabethkingia infections in humans: From genomics to clinics. Microorganisms. 2019; 7: 295. DOI: 10.3390/microorganisms7090295.
Kwambana-Adams B., Laxton C., Foster-Nyarko E. et al. Isolation of Methicillin-resistant Staphylococcus aureus and Multidrug-resistant Elizabethkingia meningoseptica from Neonates within Minutes of Birth. Pediatric Infect. Dis. J. 2017; 36: 123–4. DOI: 10.1097/INF.0000000000001368.
Huang Y., Huang Y., Lin Y. et al. Risk factors and outcome of levofloxacin-resistant Elizabethkingia meningoseptica bacteraemia in adult patients in Taiwan. Eur. J. Clin. Microbiol. Infect. Dis. 2017; 36: 1–8. DOI: 10.1007/s10096-017-2942-7.
